Janice Darlington

609 total citations
16 papers, 490 citations indexed

About

Janice Darlington is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Janice Darlington has authored 16 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pharmacology and 6 papers in Physiology. Recurrent topics in Janice Darlington's work include Asthma and respiratory diseases (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Synthesis and Biological Evaluation (4 papers). Janice Darlington is often cited by papers focused on Asthma and respiratory diseases (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Synthesis and Biological Evaluation (4 papers). Janice Darlington collaborates with scholars based in Türkiye and United States. Janice Darlington's co-authors include Gretchen Bain, John H. Hutchinson, Jilly F. Evans, Angelina M. Santini, Christopher D. King, Pat Prodanovich, Charles W. Chapman, Peppi Prasit, Lucia Correa and Daniel S. Lorrain and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

In The Last Decade

Janice Darlington

16 papers receiving 470 citations

Peers

Countries citing papers authored by Janice Darlington

Since Specialization

Citations

This map shows the geographic impact of Janice Darlington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice Darlington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice Darlington more than expected).

Fields of papers citing papers by Janice Darlington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice Darlington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice Darlington. The network helps show where Janice Darlington may publish in the future.

Co-authorship network of co-authors of Janice Darlington

This figure shows the co-authorship network connecting the top 25 collaborators of Janice Darlington. A scholar is included among the top collaborators of Janice Darlington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janice Darlington. Janice Darlington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Identification of 4-(Aminomethyl)-6-(trifluoromethyl)-2-(phenoxy)pyridine Derivatives as Potent, Selective, and Orally Efficacious Inhibitors of the Copper-Dependent Amine Oxidase, Lysyl Oxidase-Like 2 (LOXL2) 2017 ·Journal of Medicinal Chemistry ·Martin W. Rowbottom, Gretchen Bain, Imelda Calderon, (unknown), (unknown), Andiliy Lai, Fei Huang, Janice Darlington, Patricia Prodanovich, Angelina M. Santini, Christopher D. King, Lance Goulet, Kristen E. Shannon, (unknown), Katherine Nguyen, Deidre A. MacKenna, Jilly F. Evans, John H. Hutchinson	52
2	Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOX 2017 ·ACS Medicinal Chemistry Letters ·John H. Hutchinson, Martin W. Rowbottom, (unknown), Janice Darlington, Pat Prodanovich, Christopher D. King, Jilly F. Evans, Gretchen Bain	57
3	Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis 2016 ·Journal of Pharmacology and Experimental Therapeutics ·Gretchen Bain, Kristen E. Shannon, Fei Huang, Janice Darlington, Lance Goulet, Patricia Prodanovich, (unknown), Angelina M. Santini, Adam J. Stein, (unknown), Christopher D. King, Imelda Calderon, Andiliy Lai, John H. Hutchinson, Jilly F. Evans	47
4	Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding 2015 ·Molecular Pharmacology ·Adam J. Stein, Gretchen Bain, Pat Prodanovich, Angelina M. Santini, Janice Darlington, (unknown), Ranjinder S. Sidhu, Jeffrey M. Schaub, Lance Goulet, (unknown), Imelda Calderon, Jilly F. Evans, John H. Hutchinson	51
5	5-Lipoxygenase-Activating Protein (FLAP) Inhibitors. Part 4: Development of 3-[3- tert -Butylsulfanyl-1-[4-(6-ethoxypyridin-3-yl)benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1 H -indol-2-yl]-2,2-dimethylpropionic Acid (AM803), a Potent, Oral, Once Daily FLAP Inhibitor 2011 ·Journal of Medicinal Chemistry ·Nicholas Stock, Gretchen Bain, (unknown), Yiwei Li, (unknown), Jeffrey Roppe, Angelina M. Santini, Janice Darlington, Pat Prodanovich, Christopher D. King, Christopher Baccei, Catherine Lee, Haojing Rong, Charles W. Chapman, (unknown), (unknown), Lucia Correa, John H. Hutchinson, Jilly F. Evans, Peppi Prasit	39
6	Pharmacology of AM211, a Potent and Selective Prostaglandin D2 Receptor Type 2 Antagonist That Is Active in Animal Models of Allergic Inflammation 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Gretchen Bain, Daniel S. Lorrain, Karin J. Stebbins, (unknown), Angelina M. Santini, Pat Prodanovich, Janice Darlington, (unknown), Catherine Lee, Christopher Baccei, Brian A. Stearns, (unknown), John H. Hutchinson, Peppi Prasit, Jilly F. Evans	20
7	The 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor GSK2190915 , Reduces Cigarette Smoke-Induced Pulmonary Inflammation In The Mouse 2011 ·Karin J. Stebbins, (unknown), Charles W. Chapman, Lucia Correa, Angelina M. Santini, Patricia Prodanovich, Janice Darlington, Catherine Lee, Christopher Baccei, (unknown), Nicholas Stock, Gretchen Bain, Jilly F. Evans, Daniel S. Lorrain	2
8	Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation 2011 ·Arzneimittelforschung ·Burcu Çalışkan, (unknown), Luis Labeaga, Francisco José da Silva Lédo, Janice Darlington, Gretchen Bain, (unknown), Erden Banoğlu	14
9	Sodium [2′-[(cyclopropanecarbonyl-ethyl-amino)-methyl]-4′-(6-ethoxy-pyridin-3-yl)-6-methoxy-biphenyl-3-yl]-acetate (AM432): A potent, selective prostaglandin D2 receptor antagonist 2010 ·Bioorganic & Medicinal Chemistry Letters ·Nicholas Stock, Deborah L. Volkots, Karin J. Stebbins, (unknown), Brian A. Stearns, Jeffrey Roppe, Tim Parr, Christopher Baccei, Gretchen Bain, Charles W. Chapman, Lucia Correa, Janice Darlington, Christopher D. King, Catherine Lee, Daniel S. Lorrain, Pat Prodanovich, Angelina M. Santini, Jilly F. Evans, John H. Hutchinson, Peppi Prasit	9
10	Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation 2010 ·European Journal of Pharmacology ·Daniel S. Lorrain, Gretchen Bain, Lucia Correa, Charles W. Chapman, (unknown), Angelina M. Santini, Patricia Prodanovich, Janice Darlington, Nicholas Stock, (unknown), Christopher D. King, Catherine Lee, Christopher Baccei, Brian A. Stearns, Jeffrey Roppe, John H. Hutchinson, Peppi Prasit, Jilly F. Evans	19
11	Pharmacokinetic and Pharmacodynamic Characterization of an Oral Lysophosphatidic Acid Type 1 Receptor-Selective Antagonist 2010 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Charles W. Chapman, Lucia Correa, (unknown), (unknown), Gretchen Bain, Angelina M. Santini, Janice Darlington, Christopher D. King, (unknown), (unknown), (unknown), Jeffrey Roppe, (unknown), (unknown), Peppi Prasit, John H. Hutchinson, Jilly F. Evans, Daniel S. Lorrain	101
12	5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)—A potent FLAP inhibitor suitable for topical administration 2010 ·Bioorganic & Medicinal Chemistry Letters ·Nicholas Stock, Christopher Baccei, Gretchen Bain, Charles W. Chapman, Lucia Correa, Janice Darlington, Christopher D. King, Catherine Lee, Daniel S. Lorrain, Pat Prodanovich, Angelina M. Santini, (unknown), Jilly F. Evans, John H. Hutchinson, Peppi Prasit	12
13	ChemInform Abstract: Synthesis of 1,5‐Diarylpyrazol‐3‐propanoic Acids Towards Inhibition of Cyclooxygenase‐1/2 Activity and 5‐Lipoxygenase‐Mediated LTB₄ Formation. 2010 ·ChemInform ·(unknown), M. T. NUNEZ, Luis Labeaga, Francisco José da Silva Lédo, Janice Darlington, Gretchen Bain, (unknown), Erden Banoğlu	1
14	Pharmacological Characterization of 3-[3-tert-Butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic Acid (AM103), a Novel Selective 5-Lipoxygenase-Activating Protein Inhibitor That Reduces Acute and Chronic Inflammation 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Daniel S. Lorrain, Gretchen Bain, Lucia Correa, Charles W. Chapman, (unknown), Angelina M. Santini, Pat Prodanovich, Janice Darlington, John H. Hutchinson, Christopher D. King, Catherine Lee, Christopher Baccei, Yiwei Li, (unknown), Jilly F. Evans	11
15	5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5-((S)-1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy)-3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679)—A potent FLAP inhibitor 2009 ·Bioorganic & Medicinal Chemistry Letters ·Nicholas Stock, Christopher Baccei, Gretchen Bain, (unknown), Charles W. Chapman, Janice Darlington, Christopher D. King, Catherine Lee, Yiwei Li, Daniel S. Lorrain, Pat Prodanovich, Haojing Rong, Angelina M. Santini, (unknown), Jilly F. Evans, John H. Hutchinson, Peppi Prasit	20
16	5-Lipoxygenase-Activating Protein Inhibitors: Development of 3-[3-tert-Butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic Acid (AM103) 2009 ·Journal of Medicinal Chemistry ·John H. Hutchinson, Yiwei Li, (unknown), Christopher Baccei, Gretchen Bain, Charles W. Chapman, Lucia Correa, Janice Darlington, Christopher D. King, Catherine Lee, (unknown), Pat Prodanovich, Haojing Rong, Angelina M. Santini, Nicholas Stock, Peppi Prasit, Jilly F. Evans	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact